|
NDEL1 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 2.18691731390663E-12 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.57651669496772E-13 |
| Normal-vs-Stage2 |
8.560900E-04 |
| Normal-vs-Stage3 |
1.369270E-04 |
| Normal-vs-Stage4 |
7.425500E-04 |
| Stage1-vs-Stage2 |
3.067800E-01 |
| Stage1-vs-Stage3 |
3.591900E-02 |
| Stage1-vs-Stage4 |
2.767900E-02 |
| Stage2-vs-Stage3 |
6.169600E-01 |
| Stage2-vs-Stage4 |
4.533200E-01 |
| Stage3-vs-Stage4 |
7.775600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
2.54299914459466E-11 |
| Normal-vs-AfricanAmerican |
6.581500E-04 |
| Normal-vs-Asian |
1.726250E-02 |
| Caucasian-vs-AfricanAmerican |
3.610400E-01 |
| Caucasian-vs-Asian |
8.048100E-02 |
| AfricanAmerican-vs-Asian |
4.144800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
2.1599999566746E-09 |
| Normal-vs-Female |
2.8757995984563E-11 |
| Male-vs-Female |
3.858400E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
2.071600E-02 |
| Normal-vs-Age(41-60Yrs) |
2.33240093905351E-11 |
| Normal-vs-Age(61-80Yrs) |
7.41530004066959E-09 |
| Normal-vs-Age(81-100Yrs) |
1.043380E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
6.743000E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
8.340800E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
6.904400E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.432420E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
3.516000E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
6.812800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
8.385700E-04 |
| Normal-vs-Grade 2 |
2.66453525910038E-15 |
| Normal-vs-Grade 3 |
2.15109999999186E-05 |
| Normal-vs-Grade 4 |
6.658000E-03 |
| Grade 1-vs-Grade 2 |
3.841800E-02 |
| Grade 1-vs-Grade 3 |
1.035770E-03 |
| Grade 1-vs-Grade 4 |
1.480550E-03 |
| Grade 2-vs-Grade 3 |
2.448900E-04 |
| Grade 2-vs-Grade 4 |
2.721100E-03 |
| Grade 3-vs-Grade 4 |
7.430600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
5.55111512312578E-16 |
| Normal-vs-ccB subtype |
1.167260E-04 |
| ccA subtype-vs-ccB subtype |
6.192000E-04 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.35550000113227E-08 |
| Normal-vs-N1 |
8.453600E-02 |
| N0-vs-N1 |
6.920400E-01 |
|
|
